Skip to main content

This website contains promotional content and is intended for Healthcare Professionals

  1. Article
  2. Source: Campus Sanofi
  3. Sep 8, 2025

VESTIGE study

Author: Sanofi

Editorial Team

Effect of Dupilumab on Exhaled Nitric Oxide, Mucus Plugs, and Functional Respiratory Imaging in Patients With Type 2 Asthma (VESTIGE): A Randomised, Double-blind, Placebo-controlled, Phase 4 Trial

Castro M, et al. Lancet Respir Med.2025 Online first

*All characteristics are mean unless otherwise noted. bAs the primary imaging endpoint did not reach statistical significance (P>0.05), all subsequent endpoints were reported using nominal p-values. cThe statistical significance represents the correlations between 2 parameters.
ACQ, asthma control questionnaire; BD, bronchodilator; CT, computed tomography; EOS, eosinophils; FeNO, fractional exhaled nitric oxide; FEV1, forced expiratory volume in 1 second; FOT, forced oscillation technique FRI, functional residual imaging; ICS, inhaled corticosteroids; ITT, intention-to-treat; iV/Q, image-based ventilation-perfusion ratio; LS, least squares; ppFEV1, percent predicted forced expiratory volume in 1 second; q2w, every 2 weeks.

Disclaimer: This study is not added yet in to the local label in Kingdom of Saudi Arabia.

MAT-BH-2500106/V1/FEB2025  

Related